These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 31306117)
1. Relationships Between Diffusion Tensor Imaging and Cerebrospinal Fluid Metrics in Early Stages of the Alzheimer's Disease Continuum. Alm KH; Bakker A J Alzheimers Dis; 2019; 70(4):965-981. PubMed ID: 31306117 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis. Kim WH; Racine AM; Adluru N; Hwang SJ; Blennow K; Zetterberg H; Carlsson CM; Asthana S; Koscik RL; Johnson SC; Bendlin BB; Singh V Neuroimage Clin; 2019; 21():101586. PubMed ID: 30502079 [TBL] [Abstract][Full Text] [Related]
3. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease. Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038 [TBL] [Abstract][Full Text] [Related]
4. Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia. Contarino VE; Siggillino S; Arighi A; Scola E; Fumagalli GG; Conte G; Rotondo E; Galimberti D; Pietroboni AM; Carandini T; Leemans A; Bianchi AM; Triulzi FM J Alzheimers Dis; 2022; 85(1):431-442. PubMed ID: 34864664 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease. Melah KE; Lu SY; Hoscheidt SM; Alexander AL; Adluru N; Destiche DJ; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Gleason CE; Dowling NM; Bratzke LC; Rowley HA; Sager MA; Asthana S; Johnson SC; Bendlin BB J Alzheimers Dis; 2016; 50(3):873-86. PubMed ID: 26836182 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets. Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL; Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169 [TBL] [Abstract][Full Text] [Related]
7. Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer's continuum. Jiang J; Zhuo Z; Wang A; Li W; Jiang S; Duan Y; Ren Q; Zhao M; Wang L; Yang S; Awan MUN; Liu Y; Xu J Alzheimers Res Ther; 2024 Jul; 16(1):149. PubMed ID: 38961406 [TBL] [Abstract][Full Text] [Related]
8. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer's Disease. Leng F; Zhan Z; Sun Y; Liu F; Edison P; Sun Y; Wang Z; J Alzheimers Dis; 2022; 88(1):117-126. PubMed ID: 35491791 [TBL] [Abstract][Full Text] [Related]
10. CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease. Bendlin BB; Carlsson CM; Johnson SC; Zetterberg H; Blennow K; Willette AA; Okonkwo OC; Sodhi A; Ries ML; Birdsill AC; Alexander AL; Rowley HA; Puglielli L; Asthana S; Sager MA PLoS One; 2012; 7(6):e37720. PubMed ID: 22701578 [TBL] [Abstract][Full Text] [Related]
11. Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment. Canuet L; Pusil S; López ME; Bajo R; Pineda-Pardo JÁ; Cuesta P; Gálvez G; Gaztelu JM; Lourido D; García-Ribas G; Maestú F J Neurosci; 2015 Jul; 35(28):10325-30. PubMed ID: 26180207 [TBL] [Abstract][Full Text] [Related]
12. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project. van Maurik IS; Zwan MD; Tijms BM; Bouwman FH; Teunissen CE; Scheltens P; Wattjes MP; Barkhof F; Berkhof J; van der Flier WM; JAMA Neurol; 2017 Dec; 74(12):1481-1491. PubMed ID: 29049480 [TBL] [Abstract][Full Text] [Related]
13. Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes. Carandini T; Arighi A; Sacchi L; Fumagalli GG; Pietroboni AM; Ghezzi L; Colombi A; Scarioni M; Fenoglio C; De Riz MA; Marotta G; Scarpini E; Galimberti D Alzheimers Res Ther; 2019 Oct; 11(1):84. PubMed ID: 31615545 [TBL] [Abstract][Full Text] [Related]
14. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease. Leuzy A; Carter SF; Chiotis K; Almkvist O; Wall A; Nordberg A J Alzheimers Dis; 2015; 45(4):1077-88. PubMed ID: 25649653 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease. Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S; Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort. Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385 [TBL] [Abstract][Full Text] [Related]
19. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample. Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924 [TBL] [Abstract][Full Text] [Related]
20. Neurofilament relates to white matter microstructure in older adults. Moore EE; Hohman TJ; Badami FS; Pechman KR; Osborn KE; Acosta LMY; Bell SP; Babicz MA; Gifford KA; Anderson AW; Goldstein LE; Blennow K; Zetterberg H; Jefferson AL Neurobiol Aging; 2018 Oct; 70():233-241. PubMed ID: 30036759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]